Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	75.93	76.10	43.26
Graham Fair Price	-64.96	4.81	13.74
PEG	2146.92	-2.38	0.11
Price/Book	2.58	0.94	0.91
Price/Cash Flow	592.58	-165.93	23.96
Prices/Earnings	694.45	268.12	-33.75
Price/Sales	7.79	4.06	3.77
Price/FCF	592.58	-165.93	23.96
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-10.42	0.33	0.37
Operating Margin	61.02	0.02	-0.01
ROA	-87.11	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-87.09
ROIC	< 0.005	< 0.005	87.62
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	< 0.005	1201.17
Dividends QOQ	-0.03	< 0.005	75.90
EBIT QOQ	-1.25	2.51	100.32
EPS QOQ	-3.18	1.13	-64.64
FCF QOQ	0.96	-1.15	18.92
Revenue QOQ	0.03	-0.06	118.93
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	140.74	139.35	-0.99
Days Sales Outstanding (DSO)	57.54	67.00	16.45
Inventory Turnover	0.64	0.65	0.99
Debt/Capitalization	0.46	0.47	1.00
Quick Ratio	0.94	0.94	0.21
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	35.19	34.31	-2.49
Cash	5.55	4.82	-13.07
Capex	-0.20	-0.18	6.75
Free Cash Flow	1.34	-0.19	-85.56
Revenue	8.54	7.92	-7.20
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.79	1.81	1.09
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	18.71	34.19	82.76
Naive Interpretation	Member

06 - Financial Health · Weak

Rating